Feasibility of the Montreal Cognitive Assessment in acute stroke patients
Standard
Feasibility of the Montreal Cognitive Assessment in acute stroke patients. / Horstmann, S; Rizos, T; Rauch, G; Arden, C; Veltkamp, R.
in: EUR J NEUROL, Jahrgang 21, Nr. 11, 11.2014, S. 1387-1393.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Feasibility of the Montreal Cognitive Assessment in acute stroke patients
AU - Horstmann, S
AU - Rizos, T
AU - Rauch, G
AU - Arden, C
AU - Veltkamp, R
N1 - © 2014 The Author(s) European Journal of Neurology © 2014 EAN.
PY - 2014/11
Y1 - 2014/11
N2 - BACKGROUND AND PURPOSE: Cognitive deficits are common following stroke. Cognitive function in the acute stroke setting is a predictive factor for mid-term outcome. The Montreal Cognitive Assessment (MoCA) is a screening tool for cognitive impairment. The feasibility of MoCA in the acute phase of stroke was evaluated and factors predictive of cognitive impairment were determined.METHODS: In this prospective, single-centre, explorative and observational study consecutive patients with ischaemic (IS) or haemorrhagic (ICH) stroke were enrolled between March 2011 and September 2012. The routine work-up for each patient encompassed assessment of cardiovascular risk factors, the National Institutes of Health Stroke Scale (NIHSS) and the pre-morbid modified Rankin Scale (mRS) score. Cognitive performance was measured using the German version of the MoCA within the first days of admission. A MoCA score of <26 was considered to indicate cognitive impairment.RESULTS: Between March 2011 and September 2012 a total of 842 patients with IS (89.0%) and ICH (11.0%) were enrolled in our study. MoCA was feasible in 678/842 patients (80.5%). Factors independently associated with non-feasibility were stroke severity (NIHSS), pre-morbid functional status (mRS), age and lower educational level. Mean MoCA was 21.4 (SD 5.7). A total of 498/678 (73.5%) patients appeared cognitively impaired (<26/30). Independent predictive factors for a lower MoCA score were age, educational level, stroke severity (NIHSS) and pre-morbid functional status (mRS).CONCLUSIONS: In the acute phase of stroke, MoCA is feasible in about 80% of eligible patients. At this stage, MoCA identifies a cognitive impairment in 75% of patients.
AB - BACKGROUND AND PURPOSE: Cognitive deficits are common following stroke. Cognitive function in the acute stroke setting is a predictive factor for mid-term outcome. The Montreal Cognitive Assessment (MoCA) is a screening tool for cognitive impairment. The feasibility of MoCA in the acute phase of stroke was evaluated and factors predictive of cognitive impairment were determined.METHODS: In this prospective, single-centre, explorative and observational study consecutive patients with ischaemic (IS) or haemorrhagic (ICH) stroke were enrolled between March 2011 and September 2012. The routine work-up for each patient encompassed assessment of cardiovascular risk factors, the National Institutes of Health Stroke Scale (NIHSS) and the pre-morbid modified Rankin Scale (mRS) score. Cognitive performance was measured using the German version of the MoCA within the first days of admission. A MoCA score of <26 was considered to indicate cognitive impairment.RESULTS: Between March 2011 and September 2012 a total of 842 patients with IS (89.0%) and ICH (11.0%) were enrolled in our study. MoCA was feasible in 678/842 patients (80.5%). Factors independently associated with non-feasibility were stroke severity (NIHSS), pre-morbid functional status (mRS), age and lower educational level. Mean MoCA was 21.4 (SD 5.7). A total of 498/678 (73.5%) patients appeared cognitively impaired (<26/30). Independent predictive factors for a lower MoCA score were age, educational level, stroke severity (NIHSS) and pre-morbid functional status (mRS).CONCLUSIONS: In the acute phase of stroke, MoCA is feasible in about 80% of eligible patients. At this stage, MoCA identifies a cognitive impairment in 75% of patients.
KW - Aged
KW - Aged, 80 and over
KW - Cardiovascular Diseases
KW - Cognition Disorders
KW - Feasibility Studies
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Neuropsychological Tests
KW - Prospective Studies
KW - Psychometrics
KW - Stroke
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1111/ene.12505
DO - 10.1111/ene.12505
M3 - SCORING: Journal article
C2 - 25040216
VL - 21
SP - 1387
EP - 1393
JO - EUR J NEUROL
JF - EUR J NEUROL
SN - 1351-5101
IS - 11
ER -